换一批Phosphodiesterase 4 inhibitor activates AMPK-SIRT6 pathway to prevent aging-related adipose deposition induced by metabolic disorder.
第一作者：
Zhuoran,Wang
第一单位：
MOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, P.R. China.
作者：
医学主题词
3T3-L1细胞(3T3-L1 Cells);AMP活化蛋白激酶类(AMP-Activated Protein Kinases);脂肪组织(Adipose Tissue);衰老(Aging);动物(Animals);钙-钙调素依赖性蛋白激酶激酶(Calcium-Calmodulin-Dependent Protein Kinase Kinase);环AMP(Cyclic AMP);男(雄)性(Male);代谢疾病(Metabolic Diseases);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);NF-κB(NF-kappa B);磷酸二酯酶4抑制剂(Phosphodiesterase 4 Inhibitors);咯利普兰(Rolipram);信号传导(Signal Transduction);抗衰老酶(Sirtuins)
DOI
10.18632/aging.101559
PMID
30227388
发布时间
2019-11-08
- 浏览14
Aging
2394-2406页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
